Rocket Pharmaceuticals, Inc. (RCKT)
3.555
+0.08
(+2.16%)
USD |
NASDAQ |
May 01, 16:00
3.555
0.00 (0.00%)
After-Hours: 16:40
Rocket Pharmaceuticals EPS Diluted (Quarterly) : -0.3805 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arcus Biosciences, Inc. | -0.8945 |
| Replimune Group, Inc. | -0.7694 |
| Artiva Biotherapeutics, Inc. | -0.8453 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -42.54M |
| Total Expenses (Quarterly) | 42.54M |
| Enterprise Value | 213.77M |
| Earnings Yield | -56.53% |
| Normalized Earnings Yield | -55.90 |